|
MTA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.985200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.490600E-01 |
| Normal-vs-Stage2 |
7.809400E-01 |
| Normal-vs-Stage3 |
1.124600E-01 |
| Normal-vs-Stage4 |
3.895800E-01 |
| Stage1-vs-Stage2 |
8.505800E-01 |
| Stage1-vs-Stage3 |
6.596200E-02 |
| Stage1-vs-Stage4 |
2.899400E-01 |
| Stage2-vs-Stage3 |
2.937000E-01 |
| Stage2-vs-Stage4 |
3.315200E-01 |
| Stage3-vs-Stage4 |
4.863800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.418600E-01 |
| Normal-vs-AfricanAmerican |
7.429000E-01 |
| Normal-vs-Asian |
1.414400E-01 |
| Caucasian-vs-AfricanAmerican |
7.940800E-01 |
| Caucasian-vs-Asian |
8.255800E-02 |
| AfricanAmerican-vs-Asian |
1.742770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.945200E-01 |
| Normal-vs-Female |
4.503600E-01 |
| Male-vs-Female |
1.132990E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.148400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.328400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.618200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.575790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.704800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.617200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.051800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.264200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.030100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.863800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.831310E-04 |
| Classical-VS-Follicular |
2.045800E-02 |
| Classical-VS-Other |
4.179400E-01 |
| Classical-VS-Normal |
5.787000E-01 |
| Tall-VS-Follicular |
9.497700E-02 |
| Tall-VS-Other |
9.908300E-02 |
| Tall-VS-Normal |
6.883500E-03 |
| Follicular-VS-Other |
7.506300E-02 |
| Follicular-VS-Normal |
2.160600E-01 |
| Other-VS-Normal |
3.530800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.705800E-01 |
| Normal-vs-N1 |
3.327800E-01 |
| N0-vs-N1 |
1.280850E-01 |
|
|
